The latest innovation in rapid microbiology method (RMM) instrument technology is real-time viable detectors, like TSI’s BioTrak™ Real-Time Viable Particle Counter. This technology provides unique benefits for microbial contamination monitoring.
The BioTrak Particle Counter has three distinct measurement capabilities, providing maximum awareness of particulate levels present in manufacturing clean room environments. It measures total particulate count by incorporating an ISO-21501-4 compliant optical detection engine based on TSI’s field proven AeroTrak™ Airborne Particle Counters.
Particle viability is determined using TSI’s patented LIF technology developed over the past 20 years in TSI’s biological threat detection products, but optimized for the pharmaceutical application. The BioTrak Particle Counter uses two channels of fluorescence along with particle size in its discrimination of particles to better differentiate between viable particles from non-viable particles.
The BioTrak Particle Counter incorporates all this capability into a single product operated through an intuitive Graphical User Interface containing the features found in modern Airborne Particle Counters.
For more information, click here >>
|
|
|
|
|
|
|
|
|
|
|
|
Roche has announced that it will consolidate activities within its Research and Early Development division. Roche’s site in Nutley, NJ in the United States will be closed and research and development activities will be consolidated at the existing sites in Germany and Switzerland, focusing on oncology, virology, metabolism and neuroscience.
Read the full story >>
|
|
 |
|
|
|
|
|
|
|
Interphex 2012 - Exclusive video interviews
|
|
Conferences, events & exhibitions:
EuPA 2012 Scientific Congress
9 - 12 July 2012 Glasgow, Scotland
Biobanking
11 - 12 July 2012 London, UK
Drug Discovery & Diagnostic Development Week 2012
1 - 3 August 2012 San Francisco, CA, USA
Drug & Diagnostic Development
6 - 8 August 2012 San Francisco, CA, USA
Discovery Summit 2012
1 September 2012 USA
Genomics Research Europe
4 - 5 September 2012 Frankfurt, Germany
ELRIG Drug Discovery 2012
5 - 6 September 2012 Manchester, UK
HUPO 11th Annual World Congress
9 - 12 September 2012 Boston, USA
Design Control for Medical Device Professionals
10 - 11 September 2012 Berlin, Germany
Design Validation, Verification, and Risk Analysis for Medical Device Professionals
12 - 13 September 2012 Berlin, Germany
Validation of Computer Systems
17 - 18 September 2012 Dublin, Ireland
The EU Clinical Trial Directive
17 - 18 September 2012 Dublin, Ireland
|
|
|
